Inauguration of the new Morph-Im platform bioimaging facility
On 15 March 2023, Prof. Henri-François Renard and Prof. Alison Forrester introduced the new advanced bioimaging tools of the UNamur Morphology & Imaging technology platform available to a broad audience of users.
See content
NISM Annual Meeting
FNRS researcher Tárcius Nascimento Ramos publishes in the prestigious Journal of Chemical Physics
The absorption of light by molecules has applications in microscopy, medicine and data storage. With this research, the researcher from the UNamur NISM institute fills an experimental gap, which will enable molecular engineers to develop new and more efficient compounds in their various fields of application.
See content
ARTEMIS, a new project to develop new quantum sources
Yves Caudano, F.R.S.-FNRS qualified researcher, member of the NaXys and NISM Institutes and the UR-LLS (Lasers and Spectroscopies Laboratory) research unit, is taking part in a major European research project. The aim? To find new quantum light sources with unprecedented versatility, flexibility and performance.
See content
An AstraZeneca-FNRS-FWO Foundation award for Charlotte Beaudart
On 13 December 2023, Charlotte Beaudart, a new academic at the University of Namur Faculty of Medicine, will be awarded a prize at the annual ceremony for Belgian scientific research in support of her innovative research on the subject of ageing.
See content
Pollution and health of marine ecosystems | A publication that challenges current knowledge
Dr. Sébastien Mouchet, a researcher at UNamur and member of the NISM and ILEE Institutes, has just published the results of research focusing on the effects of pollution on coral reef fish in MDPI-Optics. The findings of the international, multidisciplinary team lead to crucial conclusions with implications for the health of marine ecosystems.
See content
Public thesis defense - Pauline TRICQUET
The Elongator complex is involved in the addition of 5'-carboxylmethyluridine (cm5U)-derived modifications to transfer RNAs (tRNAs), thereby influencing the translation of certain messenger RNAs (mRNAs) and helping to maintain the integrity of the proteome. This complex is involved in a variety of biological processes, and is of particular importance in oncology. The identification of chemical inhibitors of Elongator is of significant interest in both basic and pharmaceutical research.Through a yeast screen, this work reveals a potential new role for Elongator and identifies a chemical inhibitor of the complex. This compound presents itself as an interesting candidate as a pharmacological inhibitor, opening up new perspectives for the search for anti-cancer therapies.
See content
Prostate cancer under the microscope
In 1996, the European Union created the Marie Skłodowska-Curie Actions (MSCA), a set of prestigious and competitive grants designed to fund research. Thanks to her, the PROSTAMET project got underway on January 1, an ambitious program focused on training PhD students and discovering new therapeutic avenues against prostate cancer, in which UNamur is participating.
See content
NARILIS research on ageing rewarded at two scientific conferences
At UNamur's NARILIS Institute, the 'Stress and AGEing' (SAGE) research group, led by Professor Florence Chainiaux, is seeking to understand the biological processes involved in ageing, focusing on the interconnection between exposure to stress and cellular senescence.
See content
PROSTAMET - A European network for doctoral training to fight prostate cancer
Catherine Michaux, a qualified FNRS researcher, is a partner in the European MSCA-Doctoral Network PROSTAMET project. The special feature of this project is that it funds both research and the training of 9 doctoral students within a network of multidisciplinary experts.
See content
Narilis annual meeting
More info coming soon!
More info on the NARILIS website
See content
Long COVID: A study by UNamur and CHU UCL Namur unravels the biological mechanism behind the pain experienced by patients
A multidisciplinary research team from the University of Namur (UNamur) and the UCL Namur University Hospital (Godinne campus) has just published a study in the journal Acta Neuropathologica that sheds light on some of the mysteries surrounding the origin of the pain experienced by patients with long COVID. Their findings suggest that these painful symptoms may be mediated by an autoimmune response. In other words: patients produce antibodies that attack their own neurons—those responsible for pain perception and deep body sensation, located along the spine. These highly promising results represent a major scientific breakthrough that opens new avenues for better understanding the disease and, ultimately, developing a treatment targeting the painful symptoms of long COVID.
See content